lamivudine

March 3, 2015March 3, 2015

HBV Patients With Nucleotide Analogue Resistance May Benefit from TDF Monotherapy

Hepatitis B, News

Recent research reports that tenofovir disoproxil fumarate (TDF) therapy for long periods is efficient in Chinese patients with chronic hepatitis B virus (HBV) infection that have relapsed after therapy with multiple ... Read more

January 29, 2015January 29, 2015

Mylan Launches Generic Epivir-HBV® by GSK for Hepatitis B

News

Mylan Inc. announced the United States launch of their generic formulation of GlaxoSmithKline’s Epivir-HBV® Lamivudine Tablets, 100 mg. The company received the FDA’s final approval for its Abbreviated New Drug Application (ANDA), appropriated for ... Read more

December 23, 2014December 23, 2014

Recent Study Assesses Effectiveness Of Drugs To Prevent Hepatitis B

News

According to a recent study published in JAMA journal, patients with lymphoma currently undergoing a specific type of chemotherapy that includes receiving entecavir, an antiviral drug, had lower incidence of hepatitis B virus (HBV), HBV-related hepatitis ... Read more